Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Автори: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
National Institute for Health Research
2016
|
Схожі ресурси
Схожі ресурси
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
за авторством: Thomas RE Barnes, та інші
Опубліковано: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
за авторством: Barnes, T, та інші
Опубліковано: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
за авторством: Stephanie C. Chen, та інші
Опубліковано: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
за авторством: Thomas RE Barnes, та інші
Опубліковано: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
за авторством: Crawford, A, та інші
Опубліковано: (2014)